By Caroline Valetkevitch
(Reuters) - U.S. stocks were flat to lower by late afternoon Tuesday as a drop in healthcare and biotech stocks offset gains in United Technologies and Verizon.
A 5.6-percent drop in IBM
The S&P healthcare sector <.SPXHC> fell 1.3 percent, dragged down by Allergan
"You're seeing weakness in momentum names in general. Obviously the healthcare names are under pressure again, especially pharma companies," said Michael O'Rourke, chief market strategist at JonesTrading in Greenwich, Connecticut.
Stocks have mostly gained this month following a selloff in the third quarter, though concern about third-quarter earnings has added to caution in recent sessions.
More From This Section
Among those companies beating analysts' expectations, United Technologies
Also on the plus side, Verizon's
At 3:09 p.m., the Dow Jones industrial average <.DJI> rose 4.17 points, or 0.02 percent, to 17,234.71, the S&P 500 <.SPX> lost 1.44 points, or 0.07 percent, to 2,032.22 and the Nasdaq Composite <.IXIC> dropped 23.03 points, or 0.47 percent, to 4,882.45.
Earnings for S&P 500 companies are expected to have fallen about 4 percent in the third quarter, while revenue is expected to have declined 3.8 percent, according to Thomson Reuters data.
Of the S&P 500 companies that have reported so far, roughly 40 percent have beaten revenue expectations, below the long-term average, according to Thomson Reuters data.
Travelers
Shares of Tesla
Advancing issues outnumbered declining ones on the NYSE by 1,893 to 1,128, for a 1.68-to-1 ratio; on the Nasdaq, 1,393 issues rose and 1,366 fell, for a 1.02-to-1 ratio favoring advancers.
The S&P 500 posted 23 new 52-week highs and 3 lows; the Nasdaq recorded 61 new highs and 47 lows.
(Additional reporting by Abhiram Nandakumar in Bengaluru; Editing by Don Sebastian and Nick Zieminski)